KIMS.NS Profit & Loss
Krishna Institute of Medical Sciences Ltd.
Profit & Loss Balance Sheet Cash Flow
Profit & Loss · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 23:35
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Revenue from Operations | ₹21.98 Bn | ₹24.98 Bn | ₹30.35 Bn | ₹39.05 Bn | RevenueFromOperations |
| Gross Revenue (incl. inter-segment) | N/A | N/A | N/A | N/A | SegmentRevenueFromOperations |
| Other Income | ₹0.26 Bn | ₹0.13 Bn | ₹0.32 Bn | ₹0.26 Bn | OtherIncome |
| Total Income | ₹22.24 Bn | ₹25.11 Bn | ₹30.67 Bn | ₹39.31 Bn | Income |
| Cost of Materials Consumed | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | CostOfMaterialsConsumed |
| Purchases of Stock-in-Trade | ₹4.74 Bn | ₹5.37 Bn | ₹6.40 Bn | ₹8.42 Bn | PurchasesOfStockInTrade |
| Changes in Inventories | ₹0.06 Bn | ₹-0.07 Bn | ₹-0.14 Bn | ₹-0.33 Bn | ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade |
| Employee Benefit Expense | ₹3.46 Bn | ₹4.22 Bn | ₹5.00 Bn | ₹6.82 Bn | EmployeeBenefitExpense |
| Finance Costs | ₹0.31 Bn | ₹0.47 Bn | ₹0.90 Bn | ₹2.02 Bn | FinanceCosts |
| Depreciation and Amortisation | ₹1.29 Bn | ₹1.47 Bn | ₹1.77 Bn | ₹2.83 Bn | DepreciationDepletionAndAmortisationExpense |
| Other Expenses | ₹7.67 Bn | ₹9.05 Bn | ₹11.26 Bn | ₹16.12 Bn | OtherExpenses |
| Total Expenses | ₹17.53 Bn | ₹20.51 Bn | ₹25.20 Bn | ₹35.88 Bn | Expenses |
| Profit Before Exceptional Items and Tax | ₹4.70 Bn | ₹4.60 Bn | ₹5.47 Bn | ₹3.42 Bn | ProfitBeforeExceptionalItemsAndTax |
| Exceptional Items | ₹0.15 Bn | ₹0.00 Bn | ₹0.11 Bn | ₹-0.11 Bn | ExceptionalItemsBeforeTax |
| Profit Before Tax | ₹4.85 Bn | ₹4.60 Bn | ₹5.58 Bn | ₹3.31 Bn | ProfitBeforeTax |
| Tax Expense | ₹1.19 Bn | ₹1.24 Bn | ₹1.43 Bn | ₹0.92 Bn | TaxExpense |
| Net Profit (incl. minority interest) | ₹3.66 Bn | ₹3.36 Bn | ₹4.15 Bn | ₹2.42 Bn | ProfitLossForPeriod |
| Net Profit (to shareholders) | ₹3.36 Bn | ₹3.10 Bn | ₹3.85 Bn | ₹2.41 Bn | ProfitOrLossAttributableToOwnersOfParent |
| Basic EPS | ₹42.03 | ₹38.75 | ₹9.61 | ₹6.03 | BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
| Diluted EPS | ₹42.03 | ₹38.75 | ₹9.61 | ₹6.03 | DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
Every figure above is the exact value of the named XBRL element from KIMS.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).